No specific medical therapy is available in this subset when SDH-deficient GISTs are recurrent or metastatic, but the standard flow chart of GIST treatment is still recommended even though antiangiogenic drugs seem to be the most effective in terms of control of the disease. Here, SDHB is linked to gastrointestinal stromal tumor.